{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:12:05Z","timestamp":1790730725465,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10,1]]},"DOI":"10.1097\/qad.0b013e3282eea51a","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T18:04:00Z","timestamp":1236189840000},"page":"2051-2057","source":"Crossref","is-referenced-by-count":17,"title":["Prevalence and factors associated with dry skin in HIV infection: the FRAM study"],"prefix":"10.1097","volume":"21","author":[{"given":"Daniel","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance A","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora E","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Grunfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archderm.134.10.1290","article-title":"The changing spectrum of the cutaneous manifestations of HIV disease","volume":"134","author":"Costner","year":"1998","journal-title":"Arch Dermatol"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/archderm.134.10.1208","article-title":"Prevalence of cutaneous disorders in a population of HIV-infected patients. Southwestern France, 1996. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine","volume":"134","author":"Spira","year":"1998","journal-title":"Arch Dermatol"},{"key":"R3-7-20210130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0190-9622(87)70193-5","article-title":"Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex","volume":"17","author":"Goodman","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"R4-7-20210130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2133.1998.02310.x","article-title":"Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse","volume":"139","author":"Munoz-Perez","year":"1998","journal-title":"Br J Dermatol"},{"key":"R5-7-20210130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1523-1747.1999.00508.x","article-title":"Depletion of cutaneous peptidergic innervation in HIV-associated xerosis","volume":"112","author":"Rowe","year":"1999","journal-title":"J Invest Dermatol"},{"key":"R6-7-20210130","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/00002030-200005260-00025","article-title":"Decline of infectious skin manifestations in the era of highly active antiretroviral therapy","volume":"14","author":"Hengge","year":"2000","journal-title":"AIDS"},{"key":"R7-7-20210130","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/aje\/kwj111","article-title":"The Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM): methods, design, and sample characteristics","volume":"163","author":"Tien","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R8-7-20210130","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0895-4356(88)90080-7","article-title":"CARDIA: study design, recruitment, and some characteristics of the examined subjects","volume":"41","author":"Friedman","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000182230.47819.aa","article-title":"Fat distribution in men with HIV infection.","volume":"40","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/00002030-200006160-00035","article-title":"Protease inhibitor-related paronychia, ingrown toenails, desquamative cheilitis and cutaneous xerosis","volume":"14","author":"Garcia-Silva","year":"2000","journal-title":"AIDS"},{"key":"R11-7-20210130","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJM199806113382417","article-title":"Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir","volume":"338","author":"Bouscarat","year":"1998","journal-title":"N Engl J Med"},{"key":"R12-7-20210130","first-page":"277","article-title":"Indinavir-related recurrent paronychia and ingrown toenails","volume":"64","author":"Alam","year":"1999","journal-title":"Cutis"},{"key":"R13-7-20210130","first-page":"292","article-title":"Cutaneous side effects induced by indinavir","volume":"10","author":"Calista","year":"2000","journal-title":"Eur J Dermatol"},{"key":"R14-7-20210130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000018313","article-title":"Paronychia with pyogenic granuloma in a child treated with indinavir: the retinoid-mediated side effect theory revisited","volume":"200","author":"Sass","year":"2000","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/00002018-200225140-00002","article-title":"Indinavir-induced retinoid-like effects: incidence, clinical features and management","volume":"25","author":"Garcia-Silva","year":"2002","journal-title":"Drug Safety"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0733-8635(01)00011-0","article-title":"The cutaneous manifestations of HIV infection","volume":"20","author":"Garman","year":"2002","journal-title":"Dermatol Clin"},{"key":"R17-7-20210130","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/01.aids.0000131370.90575.48","article-title":"Nail, hair and skin hyperpigmentation associated with indinavir therapy","volume":"18","author":"Terheggen","year":"2004","journal-title":"AIDS"},{"key":"R18-7-20210130","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0006-2952(00)00246-X","article-title":"Stimulation of vitamin A(1) acid signaling by the HIV protease inhibitor indinavir","volume":"59","author":"Lenhard","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"R19-7-20210130","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood.V96.10.3553","article-title":"HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells","volume":"96","author":"Ikezoe","year":"2000","journal-title":"Blood"},{"key":"R20-7-20210130","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/00002030-200110190-00010","article-title":"HIV-protease inhibitors alter retinoic acid synthesis","volume":"15","author":"Toma","year":"2001","journal-title":"AIDS"},{"key":"R21-7-20210130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1742-7843.2006.pto_249.x","article-title":"Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro","volume":"98","author":"Granfors","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R22-7-20210130","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"R23-7-20210130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0190-9622(87)70066-8","article-title":"Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS)","volume":"16","author":"Kaplan","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"R24-7-20210130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2133.1997.tb03793.x","article-title":"The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression","volume":"137","author":"Uthayakumar","year":"1997","journal-title":"Br J Dermatol"},{"key":"R25-7-20210130","first-page":"565","article-title":"Cutaneous manifestations in anorexia nervosa","volume":"130","author":"Hediger","year":"2000","journal-title":"Schweiz Med Wochenschr"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200710010-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:35:32Z","timestamp":1786037732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200710010-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,1]]},"references-count":25,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3282eea51a","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1096942.552899","asserted-by":"object"}]},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10,1]]}}}